EUVIMEDEUVIMED entdecken
Crossref

Expert Council Resolution on Pathogenetically Substantiated Approach to Management and Rehabilitation of Children with Acute Intestinal Infections and Functional Gastrointestinal Disorders with the Inclusion of Probiotics and Intestinal Motility Modulators in Treatment Protocols

Leyla S. Namazova-Baranova, Aleksander V. Gorelov, Sergey V. Bel’mer, Olga S. Gundobina, Alexander S. Dukhanin, Elena V. Kaytukova, Vladimir A. Petrov, Liliya R. Selimzyanova, Denis V. Usenko, Kamilla E. Efendieva

Pediatric pharmacology · 07.07.2026 · 23 (3) · 351-360

DOI: 10.15690/pf.v23i3.3038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric pharmacology, online erschienen am 07.07.2026. Verfasst von Leyla S. Namazova-Baranova und 9 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

On March 14, 2026, the Council of Experts was held to address the issue of functional gastrointestinal disorders (FGIDs) in children, including those following acute intestinal infections (AIIs). It was noted that AIIs remain a significant medical and social problem in pediatrics, carrying risks of dehydration, toxic shock, organ damage, and the development of long-term post-infectious complications that impair quality of life. The experts confirmed the key role of baseline therapy for AIIs (oral/parenteral rehydration and diet therapy) and discussed the addition of the probiotic strain Lactobacillus rhamnosus GG (LGG) to standard protocols as an evidence-based approach to reducing the duration and severity of diarrhea and restoring gut microbiota, that may decrease the risk of subsequent FGIDs. In cases of already established FGIDs in children with a predominance of pain and spastic syndromes in the absence of organic pathology, the Council recommended thorough diagnostic evaluation and the use of trimebutine, a universal gastrointestinal motility regulator, including its novel pediatric gel formulation (Dinobutin), which provides analgesic, antispasmodic, and motility-normalizing effects and is potentially associated with higher adherence in children. It was noted that the combined use of LGG and trimebutine (for example, Normobact L and Dinobutin) may yield a more sustained clinical effect in children with FGIDs. The meeting concluded with a proposed management algorithm for patients with AIIs and post-infectious FGIDs, which could significantly improve patient outcomes and quality of life.

Zitieren

APA

Namazova-Baranova, L. S., Gorelov, A. V., Bel’mer, S. V., Gundobina, O. S., Dukhanin, A. S., Kaytukova, E. V., Petrov, V. A., Selimzyanova, L. R., Usenko, D. V., & Efendieva, K. E. (2026). Expert Council Resolution on Pathogenetically Substantiated Approach to Management and Rehabilitation of Children with Acute Intestinal Infections and Functional Gastrointestinal Disorders with the Inclusion of Probiotics and Intestinal Motility Modulators in Treatment Protocols. Pediatric pharmacology, 23(3), 351-360. https://doi.org/10.15690/pf.v23i3.3038

Vancouver

Namazova-Baranova LS, Gorelov AV, Bel’mer SV, Gundobina OS, Dukhanin AS, Kaytukova EV, et al. Expert Council Resolution on Pathogenetically Substantiated Approach to Management and Rehabilitation of Children with Acute Intestinal Infections and Functional Gastrointestinal Disorders with the Inclusion of Probiotics and Intestinal Motility Modulators in Treatment Protocols. Pediatric pharmacology. 2026;23(3):351-360. doi:10.15690/pf.v23i3.3038

BibTeX
@article{NamazovaBaranova2026,
  author = {Namazova-Baranova, Leyla S. and Gorelov, Aleksander V. and Bel’mer, Sergey V. and Gundobina, Olga S. and Dukhanin, Alexander S. and Kaytukova, Elena V. and Petrov, Vladimir A. and Selimzyanova, Liliya R. and Usenko, Denis V. and Efendieva, Kamilla E.},
  title = {Expert Council Resolution on Pathogenetically Substantiated Approach to Management and Rehabilitation of Children with Acute Intestinal Infections and Functional Gastrointestinal Disorders with the Inclusion of Probiotics and Intestinal Motility Modulators in Treatment Protocols},
  journal = {Pediatric pharmacology},
  year = {2026},
  volume = {23},
  number = {3},
  pages = {351--360},
  doi = {10.15690/pf.v23i3.3038}
}
Kostenlos starten →